{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:04:24Z","timestamp":1769011464477,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ygyno.2023.07.015","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T22:52:00Z","timestamp":1690930320000},"page":"139-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A putative role for ALDH inhibitors and chemoprevention of BRCA-mutation-driven tumors"],"prefix":"10.1016","volume":"176","author":[{"given":"Stacy","family":"McGonigal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ed","family":"Grimley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekrem G.","family":"Turk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen R.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J.","family":"Buckanovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.ygyno.2023.07.015_bb0005","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1158\/0008-5472.CAN-15-0798","article-title":"Cell-of-origin of Cancer versus Cancer stem cells: assays and interpretations","volume":"75","author":"Rycaj","year":"2015","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.ygyno.2023.07.015_bb0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajog.2013.04.019","article-title":"The role of the fallopian tube in the origin of ovarian cancer","volume":"209","author":"Erickson","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.07.015_bb0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.ygyno.2023.07.015_bb0020","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"20","key":"10.1016\/j.ygyno.2023.07.015_bb0025","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.1158\/0008-5472.CAN-09-1132","article-title":"Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer","volume":"69","author":"Carpentino","year":"2009","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2023.07.015_bb0030","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbrc.2009.05.048","article-title":"Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer","volume":"385","author":"Chen","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.ygyno.2023.07.015_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010277","article-title":"Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers","volume":"5","author":"Deng","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ygyno.2023.07.015_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002428","article-title":"Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy","volume":"3","author":"Dylla","year":"2008","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ygyno.2023.07.015_bb0045","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1158\/1541-7786.MCR-08-0393","article-title":"Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer","volume":"7","author":"Jiang","year":"2009","journal-title":"Mol. Canc. Res.: MCR"},{"issue":"7","key":"10.1016\/j.ygyno.2023.07.015_bb0050","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1158\/1541-7786.MCR-08-0035","article-title":"Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations","volume":"6","author":"Ma","year":"2008","journal-title":"Mol. Canc. Res.: MCR"},{"issue":"11","key":"10.1016\/j.ygyno.2023.07.015_bb0055","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1158\/0008-5472.CAN-10-3175","article-title":"Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival","volume":"71","author":"Silva","year":"2011","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ygyno.2023.07.015_bb0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/onc.2008.374","article-title":"Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells","volume":"28","author":"Baba","year":"2009","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.ygyno.2023.07.015_bb0065","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1002\/stem.236","article-title":"CD133 expression defines a tumor initiating cell population in primary human ovarian cancer","volume":"27","author":"Curley","year":"2009","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.ygyno.2023.07.015_bb0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ijc.25967","article-title":"Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells","volume":"130","author":"Kryczek","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2023.07.015_bb0075","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/1078-0432.CCR-11-2188","article-title":"Stem cell pathways contribute to clinical Chemoresistance in ovarian Cancer","volume":"18","author":"Steg","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"50","key":"10.1016\/j.ygyno.2023.07.015_bb0080","doi-asserted-by":"crossref","first-page":"E6882","DOI":"10.1073\/pnas.1507899112","article-title":"Identifying an ovarian cancer cell hierarchy regulated by bone morphogenetic protein 2","volume":"112","author":"Choi","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.ygyno.2023.07.015_bb0085","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.7150\/thno.41647","article-title":"An evolving paradigm of cancer stem cell hierarchies: therapeutic implications","volume":"10","author":"Cole","year":"2020","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.ygyno.2023.07.015_bb0090","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.celrep.2019.02.032","article-title":"A Pan-ALDH1A inhibitor induces necroptosis in ovarian Cancer stem-like cells","volume":"26","author":"Chefetz","year":"2019","journal-title":"Cell Rep."},{"issue":"7440","key":"10.1016\/j.ygyno.2023.07.015_bb0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nature11979","article-title":"Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche","volume":"495","author":"Flesken-Nikitin","year":"2013","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ygyno.2023.07.015_bb0100","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.7150\/thno.51885","article-title":"Aldehyde dehydrogenase inhibitors promote DNA damage in ovarian cancer and synergize with ATM\/ATR inhibitors","volume":"11","author":"Grimley","year":"2021","journal-title":"Theranostics"},{"issue":"19","key":"10.1016\/j.ygyno.2023.07.015_bb0105","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1021\/acs.jmedchem.8b00930","article-title":"Structure-based optimization of a novel class of aldehyde dehydrogenase 1A (ALDH1A) subfamily-selective inhibitors as potential adjuncts to ovarian Cancer chemotherapy","volume":"61","author":"Huddle","year":"2018","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ygyno.2023.07.015_bb0110","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/nprot.2012.097","article-title":"Primary culture and immortalization of human fallopian tube secretory epithelial cells","volume":"7","author":"Karst","year":"2012","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.ygyno.2023.07.015_bb0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1158\/1940-6207.CAPR-16-0281","article-title":"Loss of BRCA1 in the cells of origin of ovarian Cancer induces glycolysis: a window of opportunity for ovarian Cancer chemoprevention","volume":"10","author":"Chiyoda","year":"2017","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"1","key":"10.1016\/j.ygyno.2023.07.015_bb0120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/path.4927","article-title":"High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease","volume":"243","author":"Zhai","year":"2017","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.07.015_bb0125","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1038\/s41467-019-13116-2","article-title":"Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ygyno.2023.07.015_bb0130","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ygyno.2022.03.030","article-title":"Aging accelerates while multiparity delays tumorigenesis in mouse models of high-grade serous carcinoma","volume":"165","author":"Hou","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2023.07.015_bb0135","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1158\/0008-5472.CAN-21-0106","article-title":"Altering the microbiome inhibits tumorigenesis in a mouse model of Oviductal high-grade serous carcinoma","volume":"81","author":"Chen","year":"2021","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.ygyno.2023.07.015_bb0140","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1158\/0008-5472.CAN-19-2558","article-title":"Murine Oviductal high-grade serous carcinomas Mirror the genomic alterations, gene expression profiles, and immune microenvironment of their human counterparts","volume":"80","author":"McCool","year":"2020","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2023.07.015_bb0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/1541-7786.MCR-06-0234","article-title":"Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation","volume":"5","author":"DelloRusso","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ygyno.2023.07.015_bb0150","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1038\/ncomms9989","article-title":"The notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids","volume":"6","author":"Kessler","year":"2015","journal-title":"Nat. Commun."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823014166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823014166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:04:11Z","timestamp":1758773051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823014166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":30,"alternative-id":["S0090825823014166"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.07.015","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A putative role for ALDH inhibitors and chemoprevention of BRCA-mutation-driven tumors","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}